Description
Alteraciones visuales
utilizado para el tratamiento y profilaxis de hemorragias en pacientes con hemofilia A
PRINCIPIO ACTIVO: CLOBETASOL
Norepinefrina (bitartarato de norepinefrina) 4 mg
PRINCIPIO ACTIVO: ATORVASTATINA
SLENDER-DUET 120/200 MG 30 CAPS LANDSTEINER SCIENTIFIC SA Alteraciones visualesPRINCIPIO ACTIVO: ORLISTART Y L CARNITINA DOSIS: 120 200 MG PRESENTACIN: 1 CAJA
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
Red Panda | Rocket Lemon Mounstros
US$ 210.00
Invoquemos Demonios | Gen X games Piratas
US$ 325.00
Alice | Gen X Games herramientas mineras
US$ 265.00
Nucleum | Maldito Games Mas Que Oca
US$ 1175.00
recommand products
